Pharmacological treatment.
Conditions
Interventions
Intervention 1: Intervention group: The intervention group includes patients with type 2 diabetes who will take oral walnut shell capsules once a day for 3 months at the same time as taking oral anti-
Sponsors
Sanandaj University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Age over 18 years Patients with type 2 diabetes have been diagnosed with diabetes for at least 3 months. Patient cooperation Completion of the informed consent form for participation in the research program by the participants Do not take insulin Take at least one oral antidiabetic medicine (metformin) HbA1c=6.5% and FBS=126 mg / dl Lack of special diet (except diabetic diet) No chronic heart, kidney and liver failure Do not use drugs and alcohol It is good to have no mental illness and no physical condition
Exclusion criteria
Exclusion criteria: Patients taking insulin. Patients with type 1 diabetes. Patients with severe physical and mental conditions. Patients who are allergic to walnuts. Women who are pregnant or breastfeeding.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood sugar: The mean blood sugar in this study is the average fasting blood sugar of the patient. Timepoint: Before and after the intervention time. Method of measurement: Blood sample test.;Lipid profile: Lipid profile in this study is the average size of lipoproteins. Timepoint: Before and after the intervention time. Method of measurement: Blood sample test.;Glycosylated hemoglobin (HbA1c): A form of hemoglobin that is primarily used to measure the detection of moderate blood sugar levels over long periods of time. Timepoint: Before and after the intervention time. Method of measurement: Blood sample test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public Contacthossein feizi
Sanandaj University of Medical Sciences
Outcome results
None listed